Streamlining Cell Line Development | Strategies for Emerging Biotech Start-Ups

Sartorius is excited to host an in-person event on Thursday, May 26, in Cambridge, UK. Designed for biotech start-ups developing biologics, the event will highlight the advantages and disadvantages of various approaches of cell line development (CLD) and the impact early decision-making can have at later stages of biologics development. Industry leaders from Abzena, AstraZeneca, GSK will share their experiences and best practices in developing robust, stable, high-yielding cell lines.

Join us for an evening of networking and to gain insights on:

Modern cell line development workflows and their critical steps.
Various approaches to CLD and their advantages and disadvantages.
Key points to consider when evaluating external providers of CLD products and services.